-
2
-
-
0031985198
-
Multiple myeloma: Increasing evidence for a multistep transformation process
-
Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91:3-21.
-
(1998)
Blood
, vol.91
, pp. 3-21
-
-
Hallek, M.1
Bergsagel, P.L.2
Erson, K.C.3
-
3
-
-
0035194463
-
Plasma cells: Finding new light at the end of B cell development
-
Calame KL. Plasma cells: finding new light at the end of B cell development. Nature Immunology 2001; 2:1103-108.
-
(2001)
Nature Immunology
, vol.2
, pp. 1103-1108
-
-
Calame, K.L.1
-
4
-
-
0032797272
-
Chemokines and cell migration in secondary lymphoid organs
-
Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286:2098-102.
-
(1999)
Science
, vol.286
, pp. 2098-2102
-
-
Cyster, J.G.1
-
6
-
-
0035913294
-
Plasma cell differentiation requires the transcription factor XBP-1
-
Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, et al. Plasma cell differentiation requires the transcription factor XBP-1. Nature 2001; 412:300-7.
-
(2001)
Nature
, vol.412
, pp. 300-307
-
-
Reimold, A.M.1
Iwakoshi, N.N.2
Manis, J.3
Vallabhajosyula, P.4
Szomolanyi-Tsuda, E.5
Gravallese, E.M.6
-
7
-
-
0033680860
-
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
-
Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000; 13:199-212.
-
(2000)
Immunity
, vol.13
, pp. 199-212
-
-
Shaffer, A.L.1
Yu, X.2
He, Y.3
Boldrick, J.4
Chan, E.P.5
Staudt, L.M.6
-
8
-
-
0022556211
-
Antigen-driven selection of virgin and memory B cells
-
MacLennan ICM, Gray D. Antigen-driven selection of virgin and memory B cells. Immunol Rev 1986; 91:61-85.
-
(1986)
Immunol Rev
, vol.91
, pp. 61-85
-
-
Maclennan, I.1
Gray, D.2
-
9
-
-
1842294059
-
The origin of bone marrow plasma cells
-
Obrams GI, Potter M, Berlin: Springer-Verlag
-
MacLennan ICM, Chan EYT. The origin of bone marrow plasma cells. In: Obrams GI, Potter M (eds) Epidemiology biology of multiple myeloma. Berlin: Springer-Verlag, 1991:129-35.
-
(1991)
Epidemiology Biology of Multiple Myeloma
, pp. 129-135
-
-
Maclennan, I.1
Chan, E.Y.T.2
-
12
-
-
0027309118
-
Generation and regeneration of cells of the B-lymphocyte lineage
-
Rolink A, Melchers F. Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 1993; 5:207-17.
-
(1993)
Curr Opin Immunol
, vol.5
, pp. 207-217
-
-
Rolink, A.1
Melchers, F.2
-
13
-
-
0020201513
-
The normal and malignant germinal centre
-
Stein H, Gerdes J, Mason DY. The normal and malignant germinal centre. Clin Haematol 1982; 11:531-59.
-
(1982)
Clin Haematol
, vol.11
, pp. 531-559
-
-
Stein, H.1
Gerdes, J.2
Mason, D.Y.3
-
14
-
-
0029928877
-
Life and death in germinal centers (Redux)
-
Kelsoe G. Life and death in germinal centers (Redux). Immunity 1996; 4:107-11.
-
(1996)
Immunity
, vol.4
, pp. 107-111
-
-
Kelsoe, G.1
-
15
-
-
0032743853
-
The B-cell system of human mucosae and exocrine glands
-
Brandtzaeg P, Farstad IN, Johansen FE, Morton HC, Norderhaug IN, Yamanaka T. The B-cell system of human mucosae and exocrine glands. Immunol Rev 1999; 171:45-87.
-
(1999)
Immunol Rev
, vol.171
, pp. 45-87
-
-
Brandtzaeg, P.1
Farstad, I.N.2
Johansen, F.E.3
Morton, H.C.4
Norderhaug, I.N.5
Yamanaka, T.6
-
16
-
-
0019373953
-
The bone marrow: The major source of serum immunoglobulins, but still a neglected site of antibody formation
-
Benner R, Hijmans W, Haajman JJ. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol 1981; 46:1-8.
-
(1981)
Clin Exp Immunol
, vol.46
, pp. 1-8
-
-
Benner, R.1
Hijmans, W.2
Haajman, J.J.3
-
17
-
-
0025949109
-
Germinal center B cells and antibody production in the bone marrow
-
DiLosa RM, Maeda K, Masuda A, Szakal AK, Tew JG. Germinal center B cells and antibody production in the bone marrow. J Immunol 1991; 146:4071-7.
-
(1991)
J Immunol
, vol.146
, pp. 4071-4077
-
-
Dilosa, R.M.1
Maeda, K.2
Masuda, A.3
Szakal, A.K.4
Tew, J.G.5
-
18
-
-
0033152925
-
Regional specialization in the mucosal immune system: Primed cells do not always home along the same track
-
Brandtzaeg P, Farstad IN, Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today 1999; 20:267-77.
-
(1999)
Immunol Today
, vol.20
, pp. 267-277
-
-
Brandtzaeg, P.1
Farstad, I.N.2
Haraldsen, G.3
-
19
-
-
0015225148
-
Myeloma proteins (M-components) with antibody-like activity
-
Potter M. Myeloma proteins (M-components) with antibody-like activity. N Engl J Med 1971; 284:831-8.
-
(1971)
N Engl J Med
, vol.284
, pp. 831-838
-
-
Potter, M.1
-
20
-
-
0015837481
-
Antibody activity of human myeloma globulins
-
Seligmann M, Brouet JC. Antibody activity of human myeloma globulins. Semin Hematol 1973; 10:163-77.
-
(1973)
Semin Hematol
, vol.10
, pp. 163-177
-
-
Seligmann, M.1
Brouet, J.C.2
-
21
-
-
0027211999
-
Myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient
-
Konrad RJ, Kricka LJ, Goodman DBP, Goldman J, Silberstein LE. Myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med 1993; 328:1817-19.
-
(1993)
N Engl J Med
, vol.328
, pp. 1817-1819
-
-
Konrad, R.J.1
Kricka, L.J.2
Goodman, D.3
Goldman, J.4
Silberstein, L.E.5
-
22
-
-
0026786675
-
Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation
-
Bakkus MHC, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992; 80:2326-35.
-
(1992)
Blood
, vol.80
, pp. 2326-2335
-
-
Bakkus, M.1
Heirman, C.2
Van Riet, I.3
Van Camp, B.4
Thielemans, K.5
-
23
-
-
0029077309
-
Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity
-
Vescio R, Cao J, Hong CH, Lee JC, Wu CH, Der-Danielian M, et al. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol 1995; 155:2487-97.
-
(1995)
J Immunol
, vol.155
, pp. 2487-2497
-
-
Vescio, R.1
Cao, J.2
Hong, C.H.3
Lee, J.C.4
Wu, C.H.5
Der-Danielian, M.6
-
24
-
-
0029664365
-
Ig VH gene mutational pattern indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance
-
Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Ig VH gene mutational pattern indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood 1996; 87:746-55.
-
(1996)
Blood
, vol.87
, pp. 746-755
-
-
Sahota, S.S.1
Leo, R.2
Hamblin, T.J.3
Stevenson, F.K.4
-
25
-
-
0036235410
-
Plasma cells for a lifetime?
-
Manz RA, Radbruch A. Plasma cells for a lifetime? Eur J Immunol 2002; 32:923-7.
-
(2002)
Eur J Immunol
, vol.32
, pp. 923-927
-
-
Manz, R.A.1
Radbruch, A.2
-
26
-
-
0037128644
-
Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population
-
O’Connor BP, Cascalho M, Noelle RJ. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J Exp Med 2002; 195:737-45.
-
(2002)
J Exp Med
, vol.195
, pp. 737-745
-
-
O’Connor, B.P.1
Cascalho, M.2
Noelle, R.J.3
-
28
-
-
0036099832
-
Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4, CD40L T cells by producing CCL22
-
Ghia P, Strola G, Granziero L, Geuna M, Guida G, Sallusto F, et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4, CD40L T cells by producing CCL22. Eur J Immunol 2002; 32:1403-13.
-
(2002)
Eur J Immunol
, vol.32
, pp. 1403-1413
-
-
Ghia, P.1
Strola, G.2
Granziero, L.3
Geuna, M.4
Guida, G.5
Sallusto, F.6
-
29
-
-
0025885099
-
Role of bone marrow stromal cells in the growth of human multiple myeloma
-
Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schena M, et al. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 1991; 77:2688-93.
-
(1991)
Blood
, vol.77
, pp. 2688-2693
-
-
Caligaris-Cappio, F.1
Bergui, L.2
Gregoretti, M.G.3
Gaidano, G.4
Gaboli, M.5
Schena, M.6
-
30
-
-
0027405780
-
Cytokines involved in the progression of multiple myeloma
-
Merico F, Bergui L, Gregoretti MG, Ghia P, Aimo G, Lindley IJD, et al. Cytokines involved in the progression of multiple myeloma. Clin Exp Immunol 1993; 92:27-31.
-
(1993)
Clin Exp Immunol
, vol.92
, pp. 27-31
-
-
Merico, F.1
Bergui, L.2
Gregoretti, M.G.3
Ghia, P.4
Aimo, G.5
Lindley, I.6
-
31
-
-
0024548806
-
Human long-term bone marrow cultures (HLTBMCs) in myelomatous disorders
-
Bernerman ZN, Chen ZZ, Ramael M, Van Hoof V, Peetermans ME. Human long-term bone marrow cultures (HLTBMCs) in myelomatous disorders. Leukemia 1989; 3:151-4.
-
(1989)
Leukemia
, vol.3
, pp. 151-154
-
-
Bernerman, Z.N.1
Chen, Z.Z.2
Ramael, M.3
Van Hoof, V.4
Peetermans, M.E.5
-
32
-
-
0028145670
-
Characterization of bone marrow stromal cells from multiple myeloma
-
Gregoretti MG, Gottardi D, Ghia P, Bergui L, Merico F, Marchisio PC, et al. Characterization of bone marrow stromal cells from multiple myeloma. Leuk Res 1994; 18:675-8.
-
(1994)
Leuk Res
, vol.18
, pp. 675-678
-
-
Gregoretti, M.G.1
Gottardi, D.2
Ghia, P.3
Bergui, L.4
Merico, F.5
Marchisio, P.C.6
-
33
-
-
0024438022
-
Human marrow stromal cells: Response to interleukin-6 (IL-6) and control of Il-6 expression
-
Nemunaitis J, Andrews F, Mochizuki D, Lilly MB, Singer JW. Human marrow stromal cells: response to interleukin-6 (IL-6) and control of Il-6 expression. Blood 1989; 74:1929-36.
-
(1989)
Blood
, vol.74
, pp. 1929-1936
-
-
Nemunaitis, J.1
Rews, F.2
Mochizuki, D.3
Lilly, M.B.4
Singer, J.W.5
-
34
-
-
0022371075
-
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma
-
Caligaris-Cappio F, Bergui L, Tesio L, Pizzolo G, Malavasi F, Chilosi M, et al. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest 1985; 76:1243-51.
-
(1985)
J Clin Invest
, vol.76
, pp. 1243-1251
-
-
Caligaris-Cappio, F.1
Bergui, L.2
Tesio, L.3
Pizzolo, G.4
Malavasi, F.5
Chilosi, M.6
-
35
-
-
0027462898
-
In vitro culture of primary plasmacytomas requires stromal cell feeder layers
-
Degrassi A, Hilbert DM, Rudikoff S, Anderson AO, Potter M, Coon HG. In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc Natl Acad Sci USA 1993; 90:2060-4.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 2060-2064
-
-
Degrassi, A.1
Hilbert, D.M.2
Rudikoff, S.3
Erson, A.O.4
Potter, M.5
Coon, H.G.6
-
36
-
-
0026687227
-
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients
-
Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80:1818-24.
-
(1992)
Blood
, vol.80
, pp. 1818-1824
-
-
Billadeau, D.1
Quam, L.2
Thomas, W.3
Kay, N.4
Greipp, P.5
Kyle, R.6
-
37
-
-
0028904407
-
High-dose sequential chemoradiotherapy in multiple myeloma: Residual tumor cells are detectable in bone marrow and peripheral blood harvests and after autografting
-
Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M, et al. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood harvests and after autografting. Blood 1995; 85:1596-602.
-
(1995)
Blood
, vol.85
, pp. 1596-1602
-
-
Corradini, P.1
Voena, C.2
Astolfi, M.3
Ladetto, M.4
Tarella, C.5
Boccadoro, M.6
-
39
-
-
0032531999
-
A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction
-
Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood 1998; 92:2844-55.
-
(1998)
Blood
, vol.92
, pp. 2844-2855
-
-
Szczepek, A.J.1
Seeberger, K.2
Wizniak, J.3
Mant, M.J.4
Belch, A.R.5
Pilarski, L.M.6
-
40
-
-
0030049654
-
Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells
-
Chen BJ, Epstein J. Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood 1996; 87:1972-6.
-
(1996)
Blood
, vol.87
, pp. 1972-1976
-
-
Chen, B.J.1
Epstein, J.2
-
42
-
-
0027257608
-
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell
-
Billadeau D, Ahmann G, Greipp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 1993; 178:1023-31.
-
(1993)
J Exp Med
, vol.178
, pp. 1023-1031
-
-
Billadeau, D.1
Ahmann, G.2
Greipp, P.3
Van Ness, B.4
-
43
-
-
0027296754
-
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cm sequence in IgG and IgA secreting multiple myelomas
-
Corradini P, Boccadoro M, Voena C, Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cm sequence in IgG and IgA secreting multiple myelomas. J Exp Med 1993; 178:1091-6.
-
(1993)
J Exp Med
, vol.178
, pp. 1091-1096
-
-
Corradini, P.1
Boccadoro, M.2
Voena, C.3
Pileri, A.4
-
44
-
-
13344278693
-
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and differentiation
-
Dono M, Hashimoto S, Fais F, Trejo V, Allen SL, Lichtman SM, et al. Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and differentiation. Blood 1996; 87:1586-94.
-
(1996)
Blood
, vol.87
, pp. 1586-1594
-
-
Dono, M.1
Hashimoto, S.2
Fais, F.3
Trejo, V.4
Allen, S.L.5
Lichtman, S.M.6
-
45
-
-
0036493522
-
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
-
Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, Tian E, Sanderson R, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002; 99:1745-57.
-
(2002)
Blood
, vol.99
, pp. 1745-1757
-
-
Zhan, F.1
Hardin, J.2
Kordsmeier, B.3
Bumm, K.4
Zheng, M.5
Tian, E.6
Sanderson, R.7
-
46
-
-
0027234501
-
Identification of immature and mature myeloma cells in the bone marrow of human myelomas
-
Kawano MM, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, et al. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 1993; 82:564-70.
-
(1993)
Blood
, vol.82
, pp. 564-570
-
-
Kawano, M.M.1
Huang, N.2
Harada, H.3
Harada, Y.4
Sakai, A.5
Tanaka, H.6
-
47
-
-
0027316197
-
Phenotypic difference of normal plasma cells from mature myeloma cells
-
Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993; 81:2658-63.
-
(1993)
Blood
, vol.81
, pp. 2658-2663
-
-
Harada, H.1
Kawano, M.M.2
Huang, N.3
Harada, Y.4
Iwato, K.5
Tanabe, O.6
-
48
-
-
0037085786
-
The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression
-
Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002; 99:2154-61.
-
(2002)
Blood
, vol.99
, pp. 2154-2161
-
-
Medina, F.1
Segundo, C.2
Campos-Caro, A.3
Gonzalez-Garcia, I.4
Brieva, J.A.5
-
49
-
-
0036493775
-
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: A tool for comparing the efficacy of different treatment strategies and predicting outcome
-
San Miguel JF, Almeida J, Mateo G, Blade J, Lopez-Berges C, Caballero D, et al. Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome. Blood 2002; 99:1853-6.
-
(2002)
Blood
, vol.99
, pp. 1853-1856
-
-
San Miguel, J.F.1
Almeida, J.2
Mateo, G.3
Blade, J.4
Lopez-Berges, C.5
Caballero, D.6
-
50
-
-
0021364247
-
Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells
-
Malavasi F, Caligaris-Cappio F, Milanese C, Dellabona P, Richiardi P, Carbonara AO. Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol 1984; 9:9-20.
-
(1984)
Hum Immunol
, vol.9
, pp. 9-20
-
-
Malavasi, F.1
Caligaris-Cappio, F.2
Milanese, C.3
Dellabona, P.4
Richiardi, P.5
Carbonara, A.O.6
-
51
-
-
0026468136
-
Similarities in amino acid sequences of aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38
-
States DJ, Walseth TF, Lee HC. Similarities in amino acid sequences of aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38. Trends Biochem Sci 1992; 17:495-9.
-
(1992)
Trends Biochem Sci
, vol.17
, pp. 495-499
-
-
States, D.J.1
Walseth, T.F.2
Lee, H.C.3
-
52
-
-
0027452685
-
Cyclic ADP-ribose: A new way to control calcium
-
Galione A. Cyclic ADP-ribose: a new way to control calcium. Science 1993; 259:325-6.
-
(1993)
Science
, vol.259
, pp. 325-326
-
-
Galione, A.1
-
53
-
-
0032900044
-
Human myeloma cells express the CD38 ligand CD31
-
Vallario A, Chilosi M, Adami F, Montagna L, Deaglio S, Malavasi F, et al. Human myeloma cells express the CD38 ligand CD31. Br J Haematol 1999; 105:441-4.
-
(1999)
Br J Haematol
, vol.105
, pp. 441-444
-
-
Vallario, A.1
Chilosi, M.2
Adami, F.3
Montagna, L.4
Deaglio, S.5
Malavasi, F.6
-
54
-
-
0027500204
-
Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen
-
Ridley RC, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson RD. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 1993; 81:767-74.
-
(1993)
Blood
, vol.81
, pp. 767-774
-
-
Ridley, R.C.1
Xiao, H.2
Hata, H.3
Woodliff, J.4
Epstein, J.5
Sanderson, R.D.6
-
55
-
-
0034307372
-
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins
-
Borset M, Hjertner O, Yaccoby S, Epstein J, Sanderson RD. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood 2000; 96:2528-36.
-
(2000)
Blood
, vol.96
, pp. 2528-2536
-
-
Borset, M.1
Hjertner, O.2
Yaccoby, S.3
Epstein, J.4
Sanderson, R.D.5
-
56
-
-
0034329194
-
High levels of soluble syndecan-1 in myeloma-derived bone marrow: Modulation of hepatocyte growth factor activity
-
Seidel C, Borset M, Hjertner O, Cao D, Abildgaard N, Hjorth-Hansen H, et al. High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity. Blood 2000; 96:3139-46.
-
(2000)
Blood
, vol.96
, pp. 3139-3146
-
-
Seidel, C.1
Borset, M.2
Hjertner, O.3
Cao, D.4
Abildgaard, N.5
Hjorth-Hansen, H.6
-
57
-
-
0037082492
-
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
-
Derksen PWB, Keehnen RMJ, Evers LM, van Oers MHJ, Spaargaren M, Pals ST. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 2002; 99:1405-10.
-
(2002)
Blood
, vol.99
, pp. 1405-1410
-
-
Derksen, P.1
Keehnen, R.2
Evers, L.M.3
Van Oers, M.4
Spaargaren, M.5
Pals, S.T.6
-
58
-
-
0024950876
-
CD10-(CALLA)-positive lymphocytes in myeloma: Evidence that they are a malignant precursor population and are of germinal centre origin
-
Warburton, Joshua DE, Gibson J, Brown RD. CD10-(CALLA)-positive lymphocytes in myeloma:evidence that they are a malignant precursor population and are of germinal centre origin. Leuk Lymph 1989; 1:11-20.
-
(1989)
Leuk Lymph
, vol.1
, pp. 11-20
-
-
De Warburton, J.1
Gibson, J.2
Brown, R.D.3
-
59
-
-
0028846247
-
A CD10-positive subset of malignant cells is identified in multiple myeloma using PCR with patient-specific immunoglobulin gene primers
-
Cao J, Vescio RA, Rettig MB, Hong CH, Kim A, Lichtenstein AK, et al. A CD10-positive subset of malignant cells is identified in multiple myeloma using PCR with patient-specific immunoglobulin gene primers. Leukemia 1995; 9:1948-53.
-
(1995)
Leukemia
, vol.9
, pp. 1948-1953
-
-
Cao, J.1
Vescio, R.A.2
Rettig, M.B.3
Hong, C.H.4
Kim, A.5
Lichtenstein, A.K.6
-
60
-
-
0035412380
-
Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: Implications for multiple myeloma progression
-
Shapiro VS, Mollenauer MN, Weiss A. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression. Blood 2001; 98:187-93.
-
(2001)
Blood
, vol.98
, pp. 187-193
-
-
Shapiro, V.S.1
Mollenauer, M.N.2
Weiss, A.3
-
61
-
-
0026787347
-
Characterization of adhesion molecules on human myeloma cell lines
-
Uchiyama H, Barut BA, Chauhan D, Cannistra SA, Anderson KC. Characterization of adhesion molecules on human myeloma cell lines. Blood 1990; 80:2306-14.
-
(1990)
Blood
, vol.80
, pp. 2306-2314
-
-
Uchiyama, H.1
Barut, B.A.2
Chauhan, D.3
Cannistra, S.A.4
Erson, K.C.5
-
62
-
-
0025369736
-
Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)
-
Van Camp B, Durie BGM, Spier C, DeWaele M, Van Riet I, Vela, Frutiger Y, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990; 76:377-82.
-
(1990)
Blood
, vol.76
, pp. 377-382
-
-
Van Camp, B.1
Durie, B.2
Spier, C.3
Dewaele, M.4
Van Riet, I.5
-
63
-
-
0027390635
-
Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes
-
Turley EA, Belch AJ, Poppema S, Pilarski L. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 1993; 81:446-53.
-
(1993)
Blood
, vol.81
, pp. 446-453
-
-
Turley, E.A.1
Belch, A.J.2
Poppema, S.3
Pilarski, L.4
-
64
-
-
0027169432
-
The involvement of adhesion molecules in the biology of multiple myeloma
-
Van Riet I, Van Camp B. The involvement of adhesion molecules in the biology of multiple myeloma. Leuk Lymphoma 1993; 9:441-52.
-
(1993)
Leuk Lymphoma
, vol.9
, pp. 441-452
-
-
Van Riet, I.1
Van Camp, B.2
-
65
-
-
0026071476
-
Expression of the neural cell adhesion molecule (CD56) by human myeloma cells
-
Drach J, Gattringer C, Huber H. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol 1991; 83:418-22.
-
(1991)
Clin Exp Immunol
, vol.83
, pp. 418-422
-
-
Drach, J.1
Gattringer, C.2
Huber, H.3
-
66
-
-
0026661556
-
Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma
-
Ashmann EJM, Lokhorst HM, Dekker AW, Bloem AC. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood 1992; 79:2068-75.
-
(1992)
Blood
, vol.79
, pp. 2068-2075
-
-
Ashmann, E.1
Lokhorst, H.M.2
Dekker, A.W.3
Bloem, A.C.4
-
67
-
-
0029907810
-
Different CD44 splicing patterns define prognostic subgroups in multiple myeloma
-
Stauder R, Van Driel M, Schwarzler C, Thaler J, Lokhorst HM, Kreuser ED, et al. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 1996; 88:3101-8.
-
(1996)
Blood
, vol.88
, pp. 3101-3108
-
-
Stauder, R.1
Van Driel, M.2
Schwarzler, C.3
Thaler, J.4
Lokhorst, H.M.5
Kreuser, E.D.6
-
68
-
-
0035863789
-
Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1
-
Sanz-Rodriguez F, Hidalgo A, Teixidò J. Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 2001; 97:346-51.
-
(2001)
Blood
, vol.97
, pp. 346-351
-
-
Sanz-Rodriguez, F.1
Hidalgo, A.2
Teixidò, J.3
-
69
-
-
0030045099
-
Hyaluronan-dependent mobility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: Alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44
-
Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM. Hyaluronan-dependent mobility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood 1996; 87:1891-9.
-
(1996)
Blood
, vol.87
, pp. 1891-1899
-
-
Masellis-Smith, A.1
Belch, A.R.2
Mant, M.J.3
Turley, E.A.4
Pilarski, L.M.5
-
70
-
-
0036112623
-
Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation
-
Ely SA, Knowles DM. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol 2002; 160:1293-9.
-
(2002)
Am J Pathol
, vol.160
, pp. 1293-1299
-
-
Ely, S.A.1
Knowles, D.M.2
-
71
-
-
0026625773
-
Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells
-
Barker HF, Hamilton MS, Ball J, Drew M, Franklin IM. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Br J Haematol 1992; 81:331-5.
-
(1992)
Br J Haematol
, vol.81
, pp. 331-335
-
-
Barker, H.F.1
Hamilton, M.S.2
Ball, J.3
Drew, M.4
Franklin, I.M.5
-
72
-
-
0024391288
-
Response patterns of purified myeloma cells to hematopoietic growth factors
-
Anderson KC, Jones RM, Morimoto C, Leavitt P, Barut A. Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 1989; 73:1915-24.
-
(1989)
Blood
, vol.73
, pp. 1915-1924
-
-
Anderson, K.C.1
Jones, R.M.2
Morimoto, C.3
Leavitt, P.4
Barut, A.5
-
73
-
-
0024379867
-
Production of Interleuchin-1 by bone marrow myeloma cells
-
Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, et al. Production of Interleuchin-1 by bone marrow myeloma cells. Blood 1989; 74:380-7.
-
(1989)
Blood
, vol.74
, pp. 380-387
-
-
Cozzolino, F.1
Torcia, M.2
Aldinucci, D.3
Rubartelli, A.4
Miliani, A.5
Shaw, A.R.6
-
74
-
-
0016262579
-
Evidence for the secretion of an osteoclast stimulating factor in myeloma
-
Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 1974; 291:1041-6.
-
(1974)
N Engl J Med
, vol.291
, pp. 1041-1046
-
-
Mundy, G.R.1
Raisz, L.G.2
Cooper, R.A.3
Schechter, G.P.4
Salmon, S.E.5
-
75
-
-
0023227925
-
Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells
-
Ross Garrett I, Durie BGM, Nedwin GE, Gillespie A, Bringman T, Sabatini M, et al. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N Engl J Med 1987; 317:526-32.
-
(1987)
N Engl J Med
, vol.317
, pp. 526-532
-
-
Ross Garrett, I.1
Durie, B.2
Nedwin, G.E.3
Gillespie, A.4
Bringman, T.5
Sabatini, M.6
-
76
-
-
0024378902
-
Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells
-
Nakamura M, Merchav S, Carter A, Ernst TJ, Demetri GD, Furukawa Y, et al. Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells. J Immunol 1989; 143:3543-7.
-
(1989)
J Immunol
, vol.143
, pp. 3543-3547
-
-
Nakamura, M.1
Merchav, S.2
Carter, A.3
Ernst, T.J.4
Demetri, G.D.5
Furukawa, Y.6
-
77
-
-
0034651023
-
Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma
-
Tinhofer I, Marschitz I, Henn T, Egle A, Greil R. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. Blood 2000; 95:610-18.
-
(2000)
Blood
, vol.95
, pp. 610-618
-
-
Tinhofer, I.1
Marschitz, I.2
Henn, T.3
Egle, A.4
Greil, R.5
-
78
-
-
0023849455
-
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma
-
Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 1988; 332:83-6.
-
(1988)
Nature
, vol.332
, pp. 83-86
-
-
Kawano, M.1
Hirano, T.2
Matsuda, T.3
Taga, T.4
Horii, Y.5
Iwato, K.6
-
79
-
-
0024503249
-
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
-
Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, et al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73:517-26.
-
(1989)
Blood
, vol.73
, pp. 517-526
-
-
Klein, B.1
Zhang, X.G.2
Jourdan, M.3
Content, J.4
Houssiau, F.5
Aarden, L.6
-
81
-
-
0025243571
-
IL-6 as a growth factor for human multiple myeloma cells-a short overview
-
Nilsson K, Jernberg H, Pettersson M. IL-6 as a growth factor for human multiple myeloma cells-a short overview. Curr Top Microbiol Immunol 1990; 166:3-8.
-
(1990)
Curr Top Microbiol Immunol
, vol.166
, pp. 3-8
-
-
Nilsson, K.1
Jernberg, H.2
Pettersson, M.3
-
82
-
-
0025818653
-
Heterogeneity in response to Interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines
-
Jernberg H, Pettersson M, Kishimoto T, Nilsson K. Heterogeneity in response to Interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. Leukemia 1991; 5:255-65.
-
(1991)
Leukemia
, vol.5
, pp. 255-265
-
-
Jernberg, H.1
Pettersson, M.2
Kishimoto, T.3
Nilsson, K.4
-
83
-
-
0028101292
-
Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures
-
Lokhorst HM, Lamme T, deSmet M, Klein S, de Weger RA, van Oers R, et al. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood 1994; 84:2269-74.
-
(1994)
Blood
, vol.84
, pp. 2269-2274
-
-
Lokhorst, H.M.1
Lamme, T.2
Desmet, M.3
Klein, S.4
De Weger, R.A.5
Van Oers, R.6
-
84
-
-
0030041147
-
Multiple myeloma cell adhesioninduced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kB
-
Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto KI, Libermann TA, et al. Multiple myeloma cell adhesioninduced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kB. Blood 1996; 87:1104-12.
-
(1996)
Blood
, vol.87
, pp. 1104-1112
-
-
Chauhan, D.1
Uchiyama, H.2
Akbarali, Y.3
Urashima, M.4
Yamamoto, K.I.5
Libermann, T.A.6
-
85
-
-
0024832002
-
Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias
-
Bataille R, Jourdan M, Zhang XG, Klein B. Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. J Clin Invest 1989; 84:2008-11.
-
(1989)
J Clin Invest
, vol.84
, pp. 2008-2011
-
-
Bataille, R.1
Jourdan, M.2
Zhang, X.G.3
Klein, B.4
-
86
-
-
0025990893
-
Murine anti-Interleuchin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
-
Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, et al. Murine anti-Interleuchin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991; 78:1198-204.
-
(1991)
Blood
, vol.78
, pp. 1198-1204
-
-
Klein, B.1
Wijdenes, J.2
Zhang, X.G.3
Jourdan, M.4
Boiron, J.M.5
Brochier, J.6
-
87
-
-
0028786577
-
Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
-
Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 1995; 182:1461-8.
-
(1995)
J Exp Med
, vol.182
, pp. 1461-1468
-
-
Udagawa, N.1
Takahashi, N.2
Katagiri, T.3
Tamura, T.4
Wada, S.5
Findlay, D.M.6
-
89
-
-
0034353524
-
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells
-
Rawstron C, Fenton JAL, Ashcroft J, English A, Jones RA, Richards SJ, et al. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood 2000; 96:3880-6.
-
(2000)
Blood
, vol.96
, pp. 3880-3886
-
-
Rawstron, C.1
Fenton, J.2
Ashcroft, J.3
English, A.4
Jones, R.A.5
Richards, S.J.6
-
90
-
-
0028799055
-
Oncostatin M induces association of Grb2 with janus kinase JAK2 in multiple myeloma cells
-
Chauhan D, Kharbanda SM, Ogata A, Urashima M, Frank D, Malik N, et al. Oncostatin M induces association of Grb2 with janus kinase JAK2 in multiple myeloma cells. J Exp Med 1995; 182:1801-6.
-
(1995)
J Exp Med
, vol.182
, pp. 1801-1806
-
-
Chauhan, D.1
Kharbanda, S.M.2
Ogata, A.3
Urashima, M.4
Frank, D.5
Malik, N.6
-
91
-
-
0028938265
-
Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells
-
Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu ZJ, Morel-Fournier B, et al. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 1995; 85:2521-7.
-
(1995)
Blood
, vol.85
, pp. 2521-2527
-
-
Lu, Z.Y.1
Zhang, X.G.2
Rodriguez, C.3
Wijdenes, J.4
Gu, Z.J.5
Morel-Fournier, B.6
-
93
-
-
0029825852
-
Hepatocyte growth factor and its receptor c-met in multiple myeloma
-
Borset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A. Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood 1996; 88:3998-4004.
-
(1996)
Blood
, vol.88
, pp. 3998-4004
-
-
Borset, M.1
Hjorth-Hansen, H.2
Seidel, C.3
Sundan, A.4
Waage, A.5
-
94
-
-
0032006829
-
Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The nordic myeloma study group
-
Seidel C, Borset M, Turesson I, Abildgaard N, Sundan A, Waage A. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The nordic myeloma study group. Blood 1998; 91:806-12.
-
(1998)
Blood
, vol.91
, pp. 806-812
-
-
Seidel, C.1
Borset, M.2
Turesson, I.3
Abildgaard, N.4
Sundan, A.5
Waage, A.6
-
95
-
-
0034525417
-
Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: Interleukin-6, interferon-alpha and insulin-like growth factor 1
-
Jourdan M, De Vos J, Mechti N, Klein B. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Cell Death Differ 2000; 7:1244-52.
-
(2000)
Cell Death Differ
, vol.7
, pp. 1244-1252
-
-
Jourdan, M.1
De Vos, J.2
Mechti, N.3
Klein, B.4
-
96
-
-
0029812490
-
Interleukin-6 receptor superantagonists are potent inducers of human multiple myeloma cell death
-
Demartis A, Bernassola F, Savino R, Melino G, Ciliberto G. Interleukin-6 receptor superantagonists are potent inducers of human multiple myeloma cell death. Cancer Res 1996; 56:4213-18.
-
(1996)
Cancer Res
, vol.56
, pp. 4213-4218
-
-
Demartis, A.1
Bernassola, F.2
Savino, R.3
Melino, G.4
Ciliberto, G.5
-
97
-
-
0029002318
-
Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL
-
Schwarze MM, Hawley RG. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 1995; 55:2262-5.
-
(1995)
Cancer Res
, vol.55
, pp. 2262-2265
-
-
Schwarze, M.M.1
Hawley, R.G.2
-
98
-
-
0029880038
-
Role of bcl-X(L) in the control of apoptosis in murine myeloma cells
-
Gauthier ER, Piche L, Lemieux G, Lemieux R. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells. Cancer Res 1996; 56:1451-6.
-
(1996)
Cancer Res
, vol.56
, pp. 1451-1456
-
-
Gauthier, E.R.1
Piche, L.2
Lemieux, G.3
Lemieux, R.4
-
99
-
-
0037085778
-
Myeloid cell factor-1 is a critical survival factor for multiple myeloma
-
Zhang B, Gojo I, Fenton RG. Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood 2002; 99:1885-93.
-
(2002)
Blood
, vol.99
, pp. 1885-1893
-
-
Zhang, B.1
Gojo, I.2
Fenton, R.G.3
-
100
-
-
0032750492
-
Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells
-
Puthier D, Derenne S, Barille S, Moreau P, Harousseau JL, Bataille R, et al. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Br J Haematol 1999; 107:392-5.
-
(1999)
Br J Haematol
, vol.107
, pp. 392-395
-
-
Puthier, D.1
Derenne, S.2
Barille, S.3
Moreau, P.4
Harousseau, J.L.5
Bataille, R.6
-
101
-
-
0035877981
-
MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes
-
Zhou P, Levy NB, Xie H, Qian L, Lee CY, Gascoyne RD, et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 2001; 97:3902-9.
-
(2001)
Blood
, vol.97
, pp. 3902-3909
-
-
Zhou, P.1
Levy, N.B.2
Xie, H.3
Qian, L.4
Lee, C.Y.5
Gascoyne, R.D.6
-
102
-
-
0034142212
-
Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis
-
Plowright EE, Li Z, Bergsagel PL, Chesi M, Barber DL, Branch DR, et al. Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis. Blood 2000; 95:992-8.
-
(2000)
Blood
, vol.95
, pp. 992-998
-
-
Plowright, E.E.1
Li, Z.2
Bergsagel, P.L.3
Chesi, M.4
Barber, D.L.5
Branch, D.R.6
-
103
-
-
0037085796
-
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells
-
Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Blood 2002; 99:2162-71.
-
(2002)
Blood
, vol.99
, pp. 2162-2171
-
-
Mitsiades, N.1
Mitsiades, C.S.2
Poulaki, V.3
Erson, K.C.4
Treon, S.P.5
-
104
-
-
0037082473
-
+/TRAIL highly malignat plasma cells: A major pathogenetic mechanism of anemia in multiple myeloma
-
+/TRAIL highly malignat plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. Blood 2002; 99:1305-13.
-
(2002)
Blood
, vol.99
, pp. 1305-1313
-
-
Silvestris, F.1
Cafforio, P.2
Tucci, M.3
Dammacco, F.4
-
105
-
-
0035233477
-
-
Dalton WS, Bergsagel PL, Kuehl WM, Anderson KC, Harousseau JL. Multiple myeloma. Hematology 2001:157-77.
-
(2001)
Multiple Myeloma. Hematology
, pp. 157-177
-
-
Dalton, W.S.1
Bergsagel, P.L.2
Kuehl, W.M.3
Erson, K.C.4
Harousseau, J.L.5
-
106
-
-
0032984589
-
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
-
Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999; 10:105-15.
-
(1999)
Immunity
, vol.10
, pp. 105-115
-
-
Catlett-Falcone, R.1
Landowski, T.H.2
Oshiro, M.M.3
Turkson, J.4
Levitzki, A.5
Savino, R.6
-
107
-
-
0037085809
-
Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6
-
Ishikawa H, Tsuyama N, Abroun S, Liu S, Li FJ, Taniguchi O, et al. Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6. Blood 2002; 99:2172-8.
-
(2002)
Blood
, vol.99
, pp. 2172-2178
-
-
Ishikawa, H.1
Tsuyama, N.2
Abroun, S.3
Liu, S.4
Li, F.J.5
Taniguchi, O.6
-
108
-
-
0031225483
-
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
-
Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, et al. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. J Immunol 1997; 159:2212-21.
-
(1997)
J Immunol
, vol.159
, pp. 2212-2221
-
-
Ogata, A.1
Chauhan, D.2
Teoh, G.3
Treon, S.P.4
Urashima, M.5
Schlossman, R.L.6
-
109
-
-
0024811225
-
Ras oncogene mutation in multiple myeloma
-
Neri A, Murphy JP, Cro L, Ferrero D, Tarella C, Baldini L, et al. Ras oncogene mutation in multiple myeloma. J Exp Med 1989; 170:1715-25.
-
(1989)
J Exp Med
, vol.170
, pp. 1715-1725
-
-
Neri, A.1
Murphy, J.P.2
Cro, L.3
Ferrero, D.4
Tarella, C.5
Baldini, L.6
-
110
-
-
0035921689
-
Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma
-
Hideshima T, Nakamura N, Chauhan D, Anderson KC. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 2001; 20:5991-6000.
-
(2001)
Oncogene
, vol.20
, pp. 5991-6000
-
-
Hideshima, T.1
Nakamura, N.2
Chauhan, D.3
Erson, K.C.4
-
111
-
-
0034548453
-
The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: Roles in cytokine-dependent survival and proliferative responses
-
Tu Y, Gardner A, Lichtenstein A. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 2000; 60:6763-70.
-
(2000)
Cancer Res
, vol.60
, pp. 6763-6770
-
-
Tu, Y.1
Gardner, A.2
Lichtenstein, A.3
-
112
-
-
0034669945
-
Loss of PTEN expression leading to high Akt activation in human multiple myelomas
-
Hyun T, Yam A, Pece S, Xie X, Zhang J, Miki T, et al. Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood 2000; 96:3560-8.
-
(2000)
Blood
, vol.96
, pp. 3560-3568
-
-
Hyun, T.1
Yam, A.2
Pece, S.3
Xie, X.4
Zhang, J.5
Miki, T.6
-
113
-
-
0035525792
-
The AKT kinase is activated in multiple myeloma tumor cells
-
Hsu JH, Shi Y, Krajewski S, Renner S, Fisher M, Reed JC, et al. The AKT kinase is activated in multiple myeloma tumor cells. Blood 2001; 98:2853-5.
-
(2001)
Blood
, vol.98
, pp. 2853-2855
-
-
Hsu, J.H.1
Shi, Y.2
Krajewski, S.3
Renner, S.4
Fisher, M.5
Reed, J.C.6
-
114
-
-
0028362802
-
Bone marrow angiogenesis and progression in multiple myeloma
-
Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87:503-8.
-
(1994)
Br J Haematol
, vol.87
, pp. 503-508
-
-
Vacca, A.1
Ribatti, D.2
Roncali, L.3
Ranieri, G.4
Serio, G.5
Silvestris, F.6
-
115
-
-
0033134764
-
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
-
Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93:3064-73.
-
(1999)
Blood
, vol.93
, pp. 3064-3073
-
-
Vacca, A.1
Ribatti, D.2
Presta, M.3
Minischetti, M.4
Iurlaro, M.5
Ria, R.6
-
116
-
-
0033083962
-
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
-
Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999; 59: 728-33.
-
(1999)
Cancer Res
, vol.59
, pp. 728-733
-
-
Bellamy, W.T.1
Richter, L.2
Frutiger, Y.3
Grogan, T.M.4
-
117
-
-
0035207927
-
Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies
-
Bellamy WT. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies. Semin Oncol 2001; 28: 5519.
-
(2001)
Semin Oncol
, vol.28
, pp. 5519
-
-
Bellamy, W.T.1
-
118
-
-
0035210921
-
Angiogenesis in multiple myeloma
-
Rajkumar SV, Kyle RA. Angiogenesis in multiple myeloma. Semin Oncol 2001; 28:560-4.
-
(2001)
Semin Oncol
, vol.28
, pp. 560-564
-
-
Rajkumar, S.V.1
Kyle, R.A.2
-
119
-
-
0032748385
-
Antitumor activity of thalidomide in refractory multiple myeloma
-
Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999; 341:1565-71.
-
(1999)
N Engl J Med
, vol.341
, pp. 1565-1571
-
-
Singhal, S.1
Mehta, J.2
Desikan, R.3
Ayers, D.4
Roberson, P.5
Eddlemon, P.6
-
120
-
-
0034655957
-
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma
-
Dankbar B, Padrò T, Leo R, Feldmann B, Kropff M, Masters RM, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 2000; 95:2630-6.
-
(2000)
Blood
, vol.95
, pp. 2630-2636
-
-
Dankbar, B.1
Padrò, T.2
Leo, R.3
Feldmann, B.4
Kropff, M.5
Masters, R.M.6
-
121
-
-
0035195019
-
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: Therapeutic applications
-
Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, et al. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 2001; 15:1950-61.
-
(2001)
Leukemia
, vol.15
, pp. 1950-1961
-
-
Gupta, D.1
Treon, S.P.2
Shima, Y.3
Hideshima, T.4
Podar, K.5
Tai, Y.T.6
-
122
-
-
0033584243
-
Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption
-
Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 1999; 190:293-8.
-
(1999)
J Exp Med
, vol.190
, pp. 293-298
-
-
Niida, S.1
Kaku, M.2
Amano, H.3
Yoshida, H.4
Kataoka, H.5
Nishikawa, S.6
-
124
-
-
0026770377
-
Integrins: Versatility, modulation and signalling in cell adhesion
-
Hynes RO. Integrins: versatility, modulation and signalling in cell adhesion. Cell 1992; 69:11-25.
-
(1992)
Cell
, vol.69
, pp. 11-25
-
-
Hynes, R.O.1
-
125
-
-
0027459771
-
Signal transduction from the extracellular matrix
-
Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120:577-85.
-
(1993)
J Cell Biol
, vol.120
, pp. 577-585
-
-
Juliano, R.L.1
Haskill, S.2
-
127
-
-
0342322717
-
Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma
-
Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, et al. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 2000; 96:671-5.
-
(2000)
Blood
, vol.96
, pp. 671-675
-
-
Choi, S.J.1
Cruz, J.C.2
Craig, F.3
Chung, H.4
Devlin, R.D.5
Roodman, G.D.6
-
128
-
-
0033611467
-
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenensis
-
Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenensis. Nature 1999; 397:315-23.
-
(1999)
Nature
, vol.397
, pp. 315-323
-
-
Kong, Y.Y.1
Yoshida, H.2
Sarosi, I.3
Tan, H.L.4
Timms, E.5
Capparelli, C.6
-
129
-
-
0035451466
-
Connection between B lymphocyte and osteoclst differentiation pathways
-
Manabe N, Kawaguchi H, Chikuda H, Miyaura C, Inada M, Nagai R, et al. Connection between B lymphocyte and osteoclst differentiation pathways. J Immunol 2001; 167:2625-31.
-
(2001)
J Immunol
, vol.167
, pp. 2625-2631
-
-
Manabe, N.1
Kawaguchi, H.2
Chikuda, H.3
Miyaura, C.4
Inada, M.5
Nagai, R.6
-
130
-
-
0035253693
-
Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function
-
Yun TJ, Tallquist MD, Aicher A, Raffarty KL, Marshall AJ, Moon JJ, et al. Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 2001; 166:1482-91.
-
(2001)
J Immunol
, vol.166
, pp. 1482-1491
-
-
Yun, T.J.1
Tallquist, M.D.2
Aicher, A.3
Raffarty, K.L.4
Marshall, A.J.5
Moon, J.J.6
-
131
-
-
0034700846
-
New insights into role of microenvironment in multiple myeloma
-
Tricot G. New insights into role of microenvironment in multiple myeloma. Lancet 2000; 355:248-9.
-
(2000)
Lancet
, vol.355
, pp. 248-249
-
-
Tricot, G.1
-
133
-
-
0034501628
-
The tumor microenvironment as a determinant of cancer cell survival: A possible mechanism for de novo drug resistance
-
Shain KH, Landowski TH, Dalton WS. The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance. Curr Opin Oncol 2000; 12:557-63.
-
(2000)
Curr Opin Oncol
, vol.12
, pp. 557-563
-
-
Shain, K.H.1
Landowski, T.H.2
Dalton, W.S.3
|